Aicuris’s pritelivir is forecast to be a significant advancement for immunocompromised patients with refractory HSV infections.
The post ESCMID Global 2026: Pritelivir excels in immunocompromised refractory HSV patients appeared first on Clinical Trials Arena.
Nashville, Tenn.-based HCA Healthcare has laid off a “small portion” of its workforce in non-direct patient care roles, a system spokesperson said in a May 4 …
You govern every asset you own. Except one. Walk into any family office and you will find a CFO managing the cash, a wealth advisor managing …
أعلنَت وسائل إعلام مصرية عن وفاة هاني شاكر عن عمر يناهز 73 عامًا بعد تعرُّضه لمضاعفات صحية، فما الذي حدث مع أمير الغناء العربي؟
The oldest millennials are turning 45 this year. The oldest Gen Xers are now 60. So how prepared will they be to thrive in the decades …